CRISIL assigns rating to Jubilant Life Sciences’ NCDs

25 Jun 2018 Evaluate

Credit rating agency, CRISIL has assigned rating of ‘AA/Stable’ to Jubilant Life Sciences’ Non-Convertible Debentures (NCDs) worth Rs 350 crore. The rating agency has reaffirmed rating of ‘A1+’ assigned to the company’s Commercial Paper (CP) worth Rs 400 crore.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.

Jubilant Pharmova Share Price

993.60 -53.05 (-5.07%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×